Abstract
Repeated venipunctures are often aggressive, painful, and sometimes dangerous, especially with the risk of severe extravasation during the administration of anticancer chemotherapy. An implanted central catheter (ICC) can be used for chemotherapy, infusions, transfusions, and blood samples and for the administration of various medications or parenteral nutrition requiring repeated access to the venous system. The installation must be done by a trained operator in surgical aseptic conditions. To prevent complications, training, information, protocols, and evaluation are recommended. Nevertheless, some important complications may occur during installation or use of the device (hematoma, pneumothorax, thrombosis, extravasation, infection, no reflux, etc.).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kamioner D, Kriegel I. Abord veineux de longue durée. Référentiels interrégionaux des réseaux de cancérologie. Paris: AFSOS; 2010.
Ackermann M, Cosset-Delaigue MF, Kamioner D, Kriegel I. L’abord veineux de longue durée dans le cancer du sein. Dispositifs veineux implantables (DVI): indications, pose et complications. Oncologie. 2009;11(12):621–34.
Marcy PY. Central venous access: techniques and indications in oncology. Eur Radiol. 2008;18(10):2333–44.
Vescia S, Baumgärtner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19(1):9–15.
Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol. 2009;20(5):935–40.
Ackermann M, Cosset-Delaigue MF, Kamioner D, Kriegel I. Extravasation. Oncologie. 2009;11(12):634–41.
Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159–71.
Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, et al. Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port. Med Mal Infect. 2009;39(4):252–8.
Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, et al. Risk factors of catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312–9.
Beckers MM, Ruven HJ, Seldenrijk CA, Prins MH, Biesma DH. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res. 2010;125(4):318–21.
Debourdeau P, Kassab Chahmi D, Le Gal G, Kriegel I, Desruennes E, Douard MC, et al. 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol. 2009;20(9):1459–71.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kamioner, D.S. (2018). Totally Implanted Access Ports: Indications and Prevention of Complications. In: Dicato, M., Van Cutsem, E. (eds) Side Effects of Medical Cancer Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-70253-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-70253-7_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70252-0
Online ISBN: 978-3-319-70253-7
eBook Packages: MedicineMedicine (R0)